These results of 99.6–100% specificity from SARS-CoV-2 PCR-negative UCSF patients are thus comparable to the 99.6–99.8% specificity of the Architect CoV-2 IgG and IgM assays calculated from pre-COVID-19 samples (Fig. 1d). Here, CD40LG is linked to COVID-19.